---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-005553"
form_type: "8-K"
ticker: "SHPH"
cik: "0001757499"
company_name: "Shuttle Pharmaceuticals Holdings, Inc."
filed_at: "2025-04-21T23:59:59+00:00"
generated_at: "2026-05-23T10:27:11.524833+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Shuttle Pharma to present at Planet MicroCap Showcase VEGAS 2025 on April 23

## Summary
- Presentation by Dr. Anatoly Dritschilo on April 23 at 2:30 PM PT at Planet MicroCap Showcase VEGAS 2025.
- Focus on Phase 2 trial update of Ropidoxuridine + RT for glioblastoma and Shuttle Diagnostics advancements for prostate cancer.
- Company will also conduct 1x1 meetings on April 24 at the conference.
- No financial results or material changes announced.

## SEC filing metadata
- accession: 0001641172-25-005553
- form_type: 8-K
- ticker: SHPH
- cik: 0001757499
- company_name: Shuttle Pharmaceuticals Holdings, Inc.
- filed_at: 2025-04-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1757499/000164117225005553/0001641172-25-005553-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1757499/000164117225005553/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-005553
- JSON: https://secwatch.observer/filing/0001641172-25-005553.json
- Plain text: https://secwatch.observer/filing/0001641172-25-005553.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.